tiprankstipranks
Trending News
More News >
Enorama Pharma AB (SE:ERMA)
:ERMA
Sweden Market
Advertisement

Enorama Pharma AB (ERMA) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
17Bullish
4Neutral
1Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Enorama Pharma AB’s (ERMA) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Enorama Pharma AB is a Sell.
Enorama Pharma AB’s (ERMA) 20-Day exponential moving average is 2.70, while Enorama Pharma AB’s (ERMA) share price is kr2.77, making it a Buy.
Enorama Pharma AB’s (ERMA) 50-Day exponential moving average is 2.65, while Enorama Pharma AB’s (ERMA) share price is kr2.77, making it a Buy.

Enorama Pharma AB (ERMA) Pivot Points

Nov 02, 2025, 04:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.80
2.80
2.80
2.80
2.80
2.80
2.80
Fibonacci
2.80
2.80
2.80
2.80
2.80
2.80
2.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enorama Pharma AB (ERMA) Moving Averages

Nov 02, 2025, 04:44 PM
Period
Simple
Exponential
MA5
2.78Buy
2.78Buy
MA10
2.77Buy
2.75Buy
MA20
2.65Buy
2.70Buy
MA50
2.65Buy
2.65Buy
MA100
2.60Buy
2.65Buy
MA200
2.56Buy
2.72Buy
Enorama Pharma AB’s (ERMA) 10-Day exponential moving average is 2.75, while Enorama Pharma AB’s (ERMA) share price is kr2.77, making it a Buy.
Enorama Pharma AB’s (ERMA) 100-Day exponential moving average is 2.65, while Enorama Pharma AB’s (ERMA) share price is kr2.77, making it a Buy.
Enorama Pharma AB’s (ERMA) stock price is kr2.77 and Enorama Pharma AB’s (ERMA) 50-day simple moving average is 2.65, creating a Buy signal.
Enorama Pharma AB’s (ERMA) stock price is kr2.77 and Enorama Pharma AB’s (ERMA) 100-day simple moving average is 2.60, creating a Buy signal.
Enorama Pharma AB’s (ERMA) stock price is kr2.77 and Enorama Pharma AB’s (ERMA) 200-day simple moving average is 2.56, creating a Buy signal.

Enorama Pharma AB (ERMA) Technical Indicators

Nov 02, 2025, 04:44 PM
Name
Value
Implied Action
RSI (14)
55.23
Neutral
STOCH (9,6)
69.37
Neutral
STOCHRSI (14)
66.45
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
18.08
Buy
Williams %R
-36.36
Buy
CCI (14)
52.34
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
80.09
Buy
ROC
21.74
Buy
Enorama Pharma AB’s (ERMA) Relative Strength Index (RSI) is 55.23, creating a Neutral signal.
Enorama Pharma AB’s (ERMA) Trend Strength Indicator (ADX) is 18.08, creating a Buy signal.
Enorama Pharma AB’s (ERMA) Commodity Channel Index (CCI) is 52.34, creating a Neutral signal.
Enorama Pharma AB’s (ERMA) Price Rate of Change (ROC) is 21.74, creating a Buy signal.

FAQ

Is ERMA a Buy, Hold, or Sell?
Based on ERMA’s technical indicators, ERMA is a Strong Buy.
    What is ERMA’s RSI (14)?
    ERMA’s RSI (14) is 55.23, which suggests ERMA is a Neutral.
      What is ERMA’s MACD?
      ERMA’s MACD is 0.06, which suggests ERMA is a Sell.
        What is ERMA’s 5-day moving average?
        ERMA’s 5-day moving average is 2.78, which suggests ERMA is a Buy.
          What is ERMA’s 20-day moving average?
          ERMA 20-day moving average is 2.65, which suggests ERMA is a Buy.
            What is ERMA’s 50-day moving average?
            ERMA’s 50-day moving average is 2.65, which suggests ERMA is a Buy.
              What is ERMA’s 200-day moving average?
              ERMA’s 200-day moving average is 2.56, which suggests ERMA is a Buy.
                What is ERMA’s Williams % R (14)?
                ERMA’s Williams % R (14) is -36.36, which suggests ERMA is a Buy.
                  What is ERMA’s CCI (14)?
                  ERMA’s CCI (14) is 52.34, which suggests ERMA is a Neutral.
                    What is the share price of Enorama Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis